Description
Indication & Scope
AiBiTe® Famitinib Malate Capsules provides treatment of recurrent or metastatic cervical cancer in adult patients after prior systemic therapy failure.
- Mechanism: Multi-target oral tyrosine kinase inhibitor, selectively inhibits VEGFR2, PDGFR and c-KIT kinase activity, blocks tumor angiogenesis and suppresses cervical cancer cell proliferation and metastasis.
- Drug class: Oral multi-target anti-angiogenic tyrosine kinase inhibitor, gynecological tumor prescription small-molecule medicine.
- Clinical use: Late-line targeted monotherapy for refractory recurrent metastatic cervical cancer.
| Generic Name | Famitinib Malate Capsules |
| Brand Name | AiBiTe |
| Ingredient | Famitinib Malate |
| Dosage Form | Capsules |
| Package | 5mg*12 capsules*5 blisters/box |
| Conditions Treated | Recurrent or metastatic cervical cancer in adult patients with failed prior treatment |
| Taboos | Severe hypersensitivity to famitinib malate; patients with active gastrointestinal perforation or hemorrhage; pregnant women |
| Place of origin | China |
| Prescription type | Prescription-only |
| Storage Conditions | Store sealed below 25°C, light and moisture resistant |
| Manufacturer | HengRui Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20250022 |
| Approval Date | May 27, 2025 |
| Shelf Life | 30 months |
How to use ?
Recommended Dose: Fixed once-daily oral capsule dose taken continuously until disease progression.
Time: Daily consistent oral dosing for uninterrupted treatment cycles.
Instructions for use: Swallow capsules whole; regular monitoring of blood pressure, urine protein and gastrointestinal bleeding signs monthly.
Interaction: Strong CYP3A4 inhibitors elevate systemic exposure and hypertension risk, concurrent use requires dose reduction.
Side effects: Hypertension, proteinuria, hand-foot skin reaction, diarrhea, fatigue, epistaxis.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What tumor does Famitinib Malate Capsules target?
It treats recurrent or metastatic cervical cancer after prior systemic therapy failure.
What is Famitinib Malate Capsules' pharmacological mechanism?
It inhibits tumor angiogenesis by blocking VEGFR2 and other multi-target tyrosine kinases.
What severe conditions are contraindicated of Famitinib Malate Capsules?
Active gastrointestinal bleeding, perforation and severe drug hypersensitivity are absolute taboos.
What routine monitoring items are required when using Famitinib Malate Capsules?
Regular blood pressure, urine protein and gastrointestinal condition monitoring are essential.
AiBiTe® | Famitinib Malate Capsules | Cervical Cancer | DengYueRX
INN: Famitinib Malate Capsules
Indications: Cervical cancer
Dosage Form: Capsules
Strength: 5mg/capsule
